ProMetic Announces Octapharma Publication of PRDT's Prion Removal Resin in Octaplas(R) Manufacturing Process...


Marketwire Canada
June 10, 2008 - Its core business is the development, production and sale of high quality human proteins. The Company has grown to 2,500 employees in 27 countries since its founding in 1983. This technology is used in large-scale purification of biologics and the elimination of pathogens.


News Categories: